Loading...
Adherence to tyrosine kinase inhibitors among Medicare Part D beneficiaries with chronic myeloid leukemia
BACKGROUND: Tyrosine kinase inhibitors (TKIs) improve survival of chronic myeloid leukemia (CML) patients dramatically; however, non-adherence to TKI therapy may lead to resistance to the therapy. They are very expensive and covered under Part D insurance for Medicare patients. The impact of low-inc...
Na minha lista:
| Udgivet i: | Cancer |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5764158/ https://ncbi.nlm.nih.gov/pubmed/28976559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31050 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|